Conde Javier, Otero Miguel, Scotece Morena, Abella Vanessa, López Verónica, Pino Jesús, Gómez Rodolfo, Lago Francisca, Goldring Mary B, Gualillo Oreste
SERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), Research Laboratory 9, The NEIRID Lab (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases), Santiago University Clinical Hospital, Santiago de Compostela, 15706, Spain.
Tissue Engineering Regeneration and Repair Program, The Hospital for Special Surgery, and Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, NY, USA.
J Physiol. 2016 Nov 1;594(21):6133-6146. doi: 10.1113/JP272240. Epub 2016 Jul 18.
E74-like factor 3 (ELF3) is a transcription factor regulated by inflammation in different physio-pathological situations. Lipocalin-2 (LCN2) emerged as a relevant adipokine involved in the regulation of inflammation. In this study we showed for the first time the involvement of ELF3 in the control of LCN2 expression and its cooperation with nuclear factor-κB (NFκB). Our results will help to better understand of the role of ELF3, NFκB and LCN2 in the pathophysiology of articular cartilage.
E74-like factor 3 (ELF3) is a transcription factor induced by inflammatory cytokines in chondrocytes that increases gene expression of catabolic and inflammatory mediators. Lipocalin 2 (LCN2) is a novel adipokine that negatively impacts articular cartilage, triggering catabolic and inflammatory responses in chondrocytes. Here, we investigated the control of LCN2 gene expression by ELF3 in the context of interleukin 1 (IL-1)-driven inflammatory responses in chondrocytes. The interaction of ELF3 and nuclear factor-κB (NFκB) in modulating LCN2 levels was also explored. LCN2 mRNA and protein levels, as well those of several other ELF3 target genes, were determined by RT-qPCR and Western blotting. Human primary chondrocytes, primary chondrocytes from wild-type and Elf3 knockout mice, and immortalized human T/C-28a2 and murine ATDC5 cell lines were used in in vitro assays. The activities of various gene reporter constructs were evaluated by luciferase assays. Gene overexpression and knockdown were performed using specific expression vectors and siRNA technology, respectively. ELF3 overexpression transactivated the LCN2 promoter and increased the IL-1-induced mRNA and protein levels of LCN2, as well as the mRNA expression of other pro-inflammatory mediators, in human and mouse chondrocytes. We also identified a collaborative loop between ELF3 and NFκB that amplifies the induction of LCN2. Our findings show a novel role for ELF3 and NFκB in the induction of the pro-inflammatory adipokine LCN2, providing additional evidence of the interaction between ELF3 and NFκB in modulating inflammatory responses, and a better understanding of the mechanisms of action of ELF3 in chondrocytes.
E74样因子3(ELF3)是一种在不同生理病理情况下受炎症调节的转录因子。脂联素2(LCN2)是一种参与炎症调节的重要脂肪因子。在本研究中,我们首次表明ELF3参与LCN2表达的调控及其与核因子κB(NFκB)的协同作用。我们的结果将有助于更好地理解ELF3、NFκB和LCN2在关节软骨病理生理学中的作用。
E74样因子3(ELF3)是软骨细胞中由炎性细胞因子诱导的转录因子,可增加分解代谢和炎性介质的基因表达。脂联素2(LCN2)是一种新型脂肪因子,对关节软骨产生负面影响,引发软骨细胞的分解代谢和炎症反应。在此,我们研究了在白细胞介素1(IL-1)驱动的软骨细胞炎症反应背景下,ELF3对LCN2基因表达的调控。还探讨了ELF3与核因子κB(NFκB)在调节LCN2水平方面的相互作用。通过RT-qPCR和蛋白质印迹法测定LCN2 mRNA和蛋白质水平,以及其他几种ELF3靶基因的水平。在体外实验中使用了人原代软骨细胞、野生型和Elf3基因敲除小鼠的原代软骨细胞,以及永生化的人T/C-28a2和小鼠ATDC5细胞系。通过荧光素酶测定评估各种基因报告构建体的活性。分别使用特异性表达载体和siRNA技术进行基因过表达和敲低。在人和小鼠软骨细胞中,ELF3过表达激活了LCN2启动子,并增加了IL-1诱导的LCN2 mRNA和蛋白质水平,以及其他促炎介质的mRNA表达。我们还确定了ELF3和NFκB之间的协同回路,该回路放大了LCN2的诱导作用。我们的研究结果显示了ELF3和NFκB在促炎性脂肪因子LCN2诱导中的新作用,为ELF3和NFκB在调节炎症反应中的相互作用提供了额外证据,并更好地理解了ELF3在软骨细胞中的作用机制。